If the radiation therapy dose given to the participant differs from the dose recommended by the Debulk study protocol and is administered at a different level, should the participant be excluded from this study, or is it permissible to document an infringement report and continue with the study?
2023-08-31
(KGOG 1047 / GCIG study)
